All trans-retinoic acid suppresses in vitro growth and down-regulates LIF gene expression as well as telomerase activity of human medulloblastoma cells

Anticancer Research

Volumn 20, Issue 4, 2000, Pages 2659-2664

  Liu, Jia ^a   Guo, Lee ^a   Luo, Yang ^a   Li, Jun Wei ^a   Li, Hong ^a  

^a SHENYANG MEDICAL COLLEGE   (China)

Author keywords

Differentiation; LIF; Medulloblastoma; Retinoic acid; Telomerase activity

Indexed keywords

LEUKEMIA INHIBITORY FACTOR; RETINOIC ACID; TELOMERASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; ENZYME REPRESSION; HUMAN; HUMAN CELL; MEDULLOBLASTOMA; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; DOWN-REGULATION; GENE EXPRESSION REGULATION; GROWTH INHIBITORS; HUMANS; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LYMPHOKINES; MEDULLOBLASTOMA; TELOMERASE; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0033865129     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Gould VE, Jansson DS, Molenaar LB, Rorke JQ, Lee VMY, Packer RJ and Frank WW: Primitive neuroectodermal tumors of the central nervous system: patterns of expression of neuroendocrine markers, and all classes of intermediate filament proteins. Lab. Invest 62: 498-509, 1990.
2. Zerbini C, Gelber RD, Weinberg D, Sallan SE, Barnes P, Kupsky W, Scott M and Tarbell NJ: Prognostic factors in medulloblastoma including DNA ploidy. J Clin. Oncol 11: 616-622, 1993.
3. Kenigssberg R, Hong Y, Yao Y, Lemieux E, Michaud J, Tautu C, Theoret C: Effects of basic fibroblast growth factor on the differentiation, growth, and viability of a new human medulloblastoma cell line (UM-MB1). Ame J Pathol 151: 67-881, 1997.
4. Dupuis-Girod S, Hartmann O, Benhamou E, Doz F, Mechinaud F, Bouffet E, Coze C, Kalifa C, Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma? J. Neurooncol 27: 87-98, 1997.
5. Stevenson L and Echlin R: The nature and origin of some tumors of the cerebellum (medulloblastoma). Arch. Neurol, Psychiat 31: 93-109, 1934.
6. Rorke LB: The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors. J. Neuropathol. Exp. Neurol 42: 1-, 15, 1983.
7. Pietsch T, Scharmann T, Fonatsch C, Schmidt D, Ochler R, Freihoff D, Albrecht S, Wiestler OD, Zeltzer P, Reihm H: Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system. Cancer Res 54: 3278-3287, 1994.
8. Liu J, Li J-W, Gang Y, Guo L, Li H: Expression of LIF as autocrinal growth factor in human medulloblastomas. J Cancer Res Clin Oncol 125: 475-480, 1999.
9. Liu J, Li H, Hamou MF, de Tribolet N: Inhibitory effect of LIF antisense oligonucleotide on the outgrowth of human medulloblastoma cells. Chinese J Pathol, 25: 132-134, 1996.
10. Boeuf H, Hauss C, de Graeve F, Baran N, Kedinger C: Leukemia inhibitory factor-dependent transcriptional activation in embryonic stem cells. J Cell Biol 138: 1207-1217, 1997.
11. Kokunai T, Tamaki N, Matsumoto S. Differentiation of a medulloblastoma cell line mediated by protein kinase A. In: K. Tabuchi (ed.) Biological aspects of brain tumors, Tokyo Springer-Verlag, 1991, pp436-441.
12. Liu J, Li H, de Tribolet N, Jaufeerally R, Hamou MF, Van Meir EG: IL-6 stimulates growth and inhibits constitutive, protein synthesis-indenpendent apoptosis of murine B-cell hybridoma 7TD1. Cell. Immunol 155: 428-435, 1994.
13. Chomczynski PN and Sacchi N: Single-step method of RNA isolation by acid quanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem 162: 156-159, 1987.
14. Harlow, E., and Lane, D. (eds.). The antibodies. A laboratory Manual. Cold Spring Harbour Laboratory, New York, 1988.
15. Gascan H, Godard A, Ferenz C: Characterization of NH2-terminal amino acid sequence of naturral human interleukin for DA cells: leukemia inhibitory factor. J. Biol. Chem 36: 21509-21515, 1989.